Literature DB >> 2129836

The 'mosaic-like' pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapy.

K Kotzampassi1, E Eleftheriadis, H Aletras.   

Abstract

The 'mosaic-like' pattern of portal hypertensive gastric mucosa has been evaluated endoscopically in 38 patients referred for elective sclerotherapy, before the first session, after the complete eradication of varices and six months later. Of 38 patients studied, 18 patients exhibited mild, and 20 patients exhibited negative, findings of congestive gastropathy prior to sclerotherapy. Seventeen and 18 patients, respectively, developed aggravated changes of congestive gastropathy after the completion of sclerotherapy (P = 0.003). We consider that obliteration of varices by means of endoscopic sclerotherapy influences the development of gastric congestion changes in the majority of patients. However, further studies are required to relate the direction of blood flow in the portal system as well as the level of portal pressure with the congestive gastropathy findings in such patients.

Entities:  

Mesh:

Year:  1990        PMID: 2129836     DOI: 10.1111/j.1440-1746.1990.tb01121.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Nodules in antrum after variceal eradication a new finding in patients with portal hypertension.

Authors:  Pankaj Tyagi; Amarender S Puri; Brijesh C Sharma; Sanjeev Sachdeva; Ravinder K Saran; Vikram Bhatia
Journal:  Indian J Gastroenterol       Date:  2012-02-29

3.  An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia.

Authors:  Arul Thomas; David Koch; William Marsteller; David Lewin; Adrian Reuben
Journal:  Dig Dis Sci       Date:  2018-02-15       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.